knowledge landing page image

The Future of Surveillance Law in Queensland

Full Federal Court clarifies limits on the ability of an exclusive licensee to sue for infringement of a patent

This article was written by Sarah-Jane Frydman, Luke Hawthorne and Kim O'Connell.In what may be the final chapter of the long-running dispute concerning Lundbeck’s patent for its blockbuster antidepressant Lexapro®,...

07 August 2020

Extension of deadlines to submit modern slavery statements – What you need to know

For businesses who are required to submit their first modern slavery statement in Australia this year, there has been an extension of time to submit these statements by...

01 May 2020

Federal Court dismisses claim by Commonwealth for compensation for additional PBS costs

Commonwealth denied compensation for additional PBS costs following injunction restraining generic clopidogrel launch despite patent being invalidThis article was written by Matt Swinn, Kim O’Connell, Suzy Madar, Bridie...

28 April 2020

Modern slavery risks during COVID-19 – what you need to know

This article is written by Daisy Mallett and Daniel FieldingThe Australian Border Force has released guidance on how businesses can reduce the risk of vulnerable workers in their...

24 April 2020

Patent rights during COVID-19 – can the Government step in?

As the COVID-19 pandemic unfolds, new and critical needs for medicines, vaccines, diagnostics and other medical tools will continue to arise. Many of these products are patented...

03 April 2020

COVID-19: What businesses need to know about the Australian Government’s plan

Companies around Australia are developing contingency plans for the spread of the novel coronavirus. What should they expect in the way of Government action?

17 March 2020

Common questions in pelvic mesh class action resolved

The Federal Court has delivered a further judgment in the representative class action concerning transvaginal mesh products sold by Johnson & Johnson and manufactured by Ethicon Sàrl and...

10 March 2020

Novel Coronavirus: Opportunities for companies in the health sector – temporary regulatory measures for medical supplies and diagnostic tests in China and Australia

While countries around the world grapple with containment of the COVID-19 virus, a number of governments have implemented or are considering implementing special measures.

04 March 2020

Australia’s first modern slavery statements are due this year: are you ready?

If your business is caught by the Modern Slavery Act 2018 (Cth) (the Act), you may have your first modern slavery statement due this year.

24 January 2020

Applicants succeed in vaginal mesh class action

Justice Katzmann of the Federal Court of Australia has found in favour of three women in a representative action against Johnson & Johnson and two related companies in...

02 December 2019

'Neglect' in the Interim: Aged Care Royal Commission releases preliminary conclusions

The Aged Care Royal Commission into Aged Care Quality and Safety (Aged Care Royal Commission) has released its Interim Report, Neglect.

01 November 2019

Biosimilar Use In Australia: A Status Update

Despite Australia’s relatively pro-biosimilar regulatory framework, the uptake of biosimilars in Australia continues to lag behind that observed in Europe and the USA.

30 July 2019
Categories: 

This site uses cookies to enhance your experience and to help us improve the site. Please see our Privacy Policy for further information. If you continue without changing your settings, we will assume that you are happy to receive these cookies. You can change your cookie settings at any time.

For more information on which cookies we use then please refer to our Cookie Policy.